QQ客服 官方微博 反馈留言

	Structure-Based Discovery and Optimization of Benzo[&ITd&IT]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)
	Zhang, Maofeng[1,2,3]; Zhang, Yan[1,2,3]; Song, Ming[1,2]; Xue, Xiaoqian[1,2,3]; Wang, Junjian[5]; Wang, Chao[1,2]; Zhang, Cheng[1,2,4]; Li, Chenchang[1,2,4]; Xiang, Qiuping[1,2,3]; Zou, Lingjiao[1,2,3]
	2018
卷号	61期号:7页码:3037
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4315192
专题	暨南大学
作者单位	1.[1]Chinese Acad Sci, Joint Sch Life Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Biocomp, Guangzhou, Guangdong, Peoples R China 2.[2]Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China 3.[3]Univ Chinese Acad Sci, 19 Yuquan Rd, Beijing 100049, Peoples R China 4.[4]Jilin Univ, Sch Pharmaceut Sci, 1266 Fujin Rd, Changchun 130021, Jilin, Peoples R China 5.[5]Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Sacramento, CA 95817 USA 6.[6]Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Urol, Shanghai 200127, Peoples R China 7.[7]Jinan Univ, Sch Pharm, 601 Huangpu Ave West, Guangzhou 510632, Guangdong, Peoples R China
推荐引用方式 GB/T 7714	Zhang, Maofeng[1,2,3],Zhang, Yan[1,2,3],Song, Ming[1,2],et al. Structure-Based Discovery and Optimization of Benzo[&ITd&IT]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)[J],2018,61(7):3037.
APA	Zhang, Maofeng[1,2,3].,Zhang, Yan[1,2,3].,Song, Ming[1,2].,Xue, Xiaoqian[1,2,3].,Wang, Junjian[5].,...&Xu, Yong[1,2].(2018).Structure-Based Discovery and Optimization of Benzo[&ITd&IT]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC).,61(7),3037.
MLA	Zhang, Maofeng[1,2,3],et al."Structure-Based Discovery and Optimization of Benzo[&ITd&IT]isoxazole Derivatives as Potent and Selective BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC)".61.7(2018):3037.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。